Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Graft Rejection
|
phenotype |
|
Organ or Tissue Function
|
47
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2016 |
Immune thrombocytopenic purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
338
|
35
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2014 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2017 |
Renal fibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
570
|
1
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Pulmonary Fibrosis
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
924
|
25
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Hepatitis
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
656
|
42
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2019 |
Lupus Nephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
503
|
64
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2010 |
Adult-Onset Still Disease
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
76
|
5
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Hepatitis A
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
451
|
27
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2019 |
Ectromelia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
30
|
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Crohn Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1382
|
1147
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2007 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Macrophage Activation Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
57
|
6
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.020 |
None |
0.500 |
2 |
|
2003 |
2015 |
Histiocytosis haematophagic
|
disease |
|
Disease or Syndrome
|
36
|
2
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Primary Sjögren's syndrome
|
disease |
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
312
|
42
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Neuropathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
484
|
110
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Peripheral Arterial Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
319
|
128
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Viral hepatitis
|
group |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
79
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |